FIELD: biotechnologies.
SUBSTANCE: variant immunoglobulins are provided with one or several amino acid modifications in an Fc-section, which have increased time of half-life, as well as methods of their application.
EFFECT: possibility to use compounds in medicine.
21 cl, 57 dwg, 3 tbl, 15 ex
| Title | Year | Author | Number |
|---|---|---|---|
| Fc-VERSIONS WITH ALTERED BINDING WITH FcRn | 2008 |
|
RU2517621C2 |
| VARIANTS OF Fc-DOMAIN WITH MODIFIED FcRn BINDING AND METHODS OF APPLICATION THEREOF | 2015 |
|
RU2714116C2 |
| GENETICALLY ENGINEERED POLYPEPTIDES AND USE THEREOF | 2017 |
|
RU2822498C2 |
| Fc VERSIONS WITH MODIFIED BINDING WITH FcRn | 2008 |
|
RU2529951C2 |
| VARIANTS OF Fc WITH CHANGED BINDING WITH FcRn | 2014 |
|
RU2700882C2 |
| POLYPEPTIDE VARIANTS WITH CHANGED EFFECTOR FUNCTION | 2005 |
|
RU2367667C2 |
| POLYPEPTIDES CONTAINING Fc-SECTION THAT DISPLAY INCREASED EFFECTOR FUNCTION OWING TO VARYING FUCOSYLATION LEVEL AND THEIR APPLICATIONS | 2010 |
|
RU2583298C2 |
| Fc-RECEPTOR BINDING MODIFIED ASYMMETRIC ANTIBODIES AND METHODS OF USE | 2014 |
|
RU2687043C2 |
| NOVEL ANTIBODIES | 2008 |
|
RU2490277C2 |
| Fc OPTIONS WITH INCREASED FcRn BINDING AND PROLONGED HALF-LIFE | 2019 |
|
RU2795592C2 |
